Veracyte | VCYT - Umsatzkosten





Umsatzkosten Veränderung Datum
Agenus USD 642K 399K 2025-09
Agilent USD 845M 7M 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
Bruker USD 443.6M 84.4M 2026-03
Heron Therapeutics USD 11.12M 795K 2025-12
Illumina USD 370M 30M 2026-03
Intrexon USD 1.01M 344K 2024-06
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Laboratory Of America USD 2.6B 4.2M 2026-03
Ligand Pharmaceuticals USD 11.37M 8.38M 2026-03
Myriad Genetics USD 63M 1.1M 2025-12
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Roche Holding CHF 7.85B 630M 2026-06
Sangamo BioSciences 2.42M 1.11M 2024-06
Siemens EUR 12.07B 565M 2026-03
Sonic Healthcare AUD 751.66M 801.13M 2024-12
Thermo Fisher Scientific USD 7.54B 577M 2026-06
Veracyte USD 38.49M 794K 2026-03
Waters USD 725M 350.06M 2026-03